Plunkett Research Online: Cortexyme Inc

CORTEXYME INC (CRTX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cortexyme Inc is a clinical stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis, or P. gingivalis, and its secreted toxic v.....



Cortexyme Inc
Ticker: CRTX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 415 910-5717
Fax:
Address: 269 East Grand Avenue
South San Francisco, CA 94080 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
ContactsDescription

Casey LynchCEO/Chairman of the Board/Director/President
Christopher LoweCFO/Treasurer
See More
Cortexyme Inc is a clinical stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis, or P. gingivalis, and its secreted toxic v.....See More See More

Auditor: BDO USA, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: